Re:Scientific Stagnation
by nabla9 on Tuesday October 14, 2014 @06:17AM
(#8452701)
Comment on drug discovery:
Drug industry have been criticized for exaggerating their R&D numbers. Critics also claim that private funding is directed towards drugs that contain active moieties that are same or closely related to active moieties in products that have been previously approved by FDA and that wast majority of important breakthrough drugs are the result of publicly funded research. If someone discovers drug that already works and makes billions, it justifies pushing new molecule that has same functionality but is covered with different patents.
FDA approves typically less than new 30 NCE:s per year. Some are classified as NCE:s just for administrative purposes.
Drug industry have been criticized for exaggerating their R&D numbers. Critics also claim that private funding is directed towards drugs that contain active moieties that are same or closely related to active moieties in products that have been previously approved by FDA and that wast majority of important breakthrough drugs are the result of publicly funded research. If someone discovers drug that already works and makes billions, it justifies pushing new molecule that has same functionality but is covered with different patents.
FDA approves typically less than new 30 NCE:s per year. Some are classified as NCE:s just for administrative purposes.